---
title: "CQP: Expected net profit growth of 9.2%—26% year-on-year in the first half of 2025"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248143128.md"
description: "CQP announced that it expects the net profit attributable to shareholders of the listed company for the period from January 1, 2025, to June 30, 2025, to be between 260 million and 300 million yuan, a year-on-year increase of 9.2% to 26%. The net profit after deducting non-recurring gains and losses is expected to be between 250 million and 280 million yuan, a year-on-year increase of 14.39% to 28.12%. The basic earnings per share are expected to be between 0.15 yuan/share and 0.17 yuan/share"
datetime: "2025-07-11T10:09:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248143128.md)
  - [en](https://longbridge.com/en/news/248143128.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248143128.md)
generator: "portal-rs"
---

# CQP: Expected net profit growth of 9.2%—26% year-on-year in the first half of 2025

CQP announced that it expects the net profit attributable to shareholders of the listed company from January 1, 2025, to June 30, 2025, to be between 260 million and 300 million yuan, a year-on-year increase of 9.2% to 26%. The net profit after deducting non-recurring gains and losses is expected to be between 250 million and 280 million yuan, a year-on-year increase of 14.39% to 28.12%. The basic earnings per share are expected to be between 0.15 yuan/share and 0.17 yuan/share

### Related Stocks

- [000950.CN](https://longbridge.com/en/quote/000950.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [Oura exploring how its ring could detect brain hemorrhages after Bill Ackman suggests it could have helped his daughter](https://longbridge.com/en/news/296658401.md)
- [Dajin Heavy Industry calls extraordinary general meeting](https://longbridge.com/en/news/296615574.md)
- [08:38 ETThe 2027 NAMM Show Announces Global Five-Day Celebration of Music, Product Innovation and Industry Leadership](https://longbridge.com/en/news/296229778.md)
- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**